Non-invasive metabolic testing is often discussed as if it must deliver real-time blood glucose values. In practice, another market may develop faster: long-term glycation risk screening through nails, skin, and other stable tissues. For IVD companies and distributors, this category deserves attention because it can be positioned as a complementary screening tool rather than a … Read more
Non-invasive glucose monitoring is moving from a long-standing laboratory ambition into a serious consumer health discussion. For IVD distributors, POCT brands, and diagnostic manufacturers, the important question is not whether a wristwatch can replace a regulated glucose meter tomorrow. The more practical question is how the market will behave when consumers begin to expect metabolic … Read more
Troubleshooting guidance for CRISPR-Cas12/13 lateral-flow workflows, including weak test lines, background signal, and inconsistent control lines.
A deployment checklist for distributors and program managers introducing microfluidic PCR in decentralized testing settings.
How distributors can position time-resolved fluorescence immunoassay analyzers for laboratories that need higher sensitivity than visual rapid tests.
Quality-control points for nucleic-acid lateral-flow strips used in RAA, RPA, LAMP, and CRISPR workflows.
A practical distributor checklist for evaluating RAA/RPA reagent suppliers, OEM readiness, documentation, stability, and lateral-flow workflow compatibility.
Abstract A distributor-ready IVD product page must do more than show a catalog image. It should answer procurement questions, provide technical evidence, support regulatory review, and be understandable by both human buyers and AI search systems. For IVD Reagents OEM/ODM suppliers, structured product content is now part of international business development. Introduction Distributors often begin … Read more
Abstract Time-resolved fluorescence (TRF) immunoassay technology uses delayed signal measurement to reduce background interference and improve sensitivity. For distributors building a differentiated POCT portfolio, a TRF immunoassay analyzer can offer stronger positioning than conventional visual rapid tests. The key advantage is not only higher sensitivity but also quantitative output, broader marker potential, and professional clinical … Read more
Abstract Microfluidic PCR systems can bring molecular diagnostics closer to clinics, emergency rooms, and distributed testing sites. For IVD distributors, however, importing a microfluidic PCR platform requires more than comparing instrument prices. The cartridge design, thermal control, contamination prevention, reagent stability, and registration documentation all affect commercial success. Introduction Decentralized molecular testing is growing because … Read more